脂质体增强5型腺病毒六邻体和纤维疫苗的免疫原性
Liposomal enhancement of the immunogenicity of adenovirus type 5 hexon and fiber vaccines.
作者信息
Kramp W J, Six H R, Drake S, Kasel J A
出版信息
Infect Immun. 1979 Aug;25(2):771-3. doi: 10.1128/iai.25.2.771-773.1979.
Abstract
Immunogenicity of adenovirus capsid proteins carried in liposomes was comparable to that with equivalent doses administered in Freund adjuvant, and both forms were more potent than aqueous vaccines.
摘要
脂质体携带的腺病毒衣壳蛋白的免疫原性与在弗氏佐剂中给予等量剂量的免疫原性相当，并且这两种形式都比水性疫苗更有效。
相似文献
1
Liposomal enhancement of the immunogenicity of adenovirus type 5 hexon and fiber vaccines.脂质体增强5型腺病毒六邻体和纤维疫苗的免疫原性
Infect Immun. 1979 Aug;25(2):771-3. doi: 10.1128/iai.25.2.771-773.1979.
2
Postimmunization clearance of liposome entrapped adenovirus type 5 hexon.脂质体包裹的5型腺病毒六邻体免疫接种后的清除情况
Proc Soc Exp Biol Med. 1982 Jan;169(1):135-9. doi: 10.3181/00379727-169-41321.
3
[Radioimmunological study of the antigenic determinants of human adenovirus 1 hexon].[人腺病毒1型六邻体抗原决定簇的放射免疫研究]
Mikrobiol Zh (1978). 1982 May-Jun;44(3):51-6.
4
[Immunofluorescent study of the specificity of the hexon determinants in adenovirus-infected cells].[腺病毒感染细胞中六邻体决定簇特异性的免疫荧光研究]
Mikrobiol Zh (1978). 1982 Sep-Oct;44(5):65-70.
5
[The N-terminal peptide of the hexon of human adenovirus type 2: its chemical synthesis and antigenic properties].[人腺病毒2型六邻体的N端肽：其化学合成及抗原特性]
Mikrobiol Zh (1978). 1991 Sep-Oct;53(5):53-8.
6
Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein.针对5型腺病毒疫苗载体的中和抗体主要针对腺病毒六邻体蛋白。
J Immunol. 2005 Jun 1;174(11):7179-85. doi: 10.4049/jimmunol.174.11.7179.
7
Analysis of adenovirus transforming proteins from early regions 1A and 1B with antisera to inducible fusion antigens produced in Escherichia coli.用针对在大肠杆菌中产生的可诱导融合抗原的抗血清分析来自早期区域1A和1B的腺病毒转化蛋白。
J Virol. 1984 Jan;49(1):132-41. doi: 10.1128/JVI.49.1.132-141.1984.
8
Construction and characterization of a recombinant human adenovirus type 3 vector containing two foreign neutralizing epitopes in hexon.构建并鉴定含有六邻体两个中和表位的重组人 3 型腺病毒载体。
Virus Res. 2014 Apr;183:67-74. doi: 10.1016/j.virusres.2014.01.027. Epub 2014 Feb 8.
9
Humoral immune response to the capsid components of recombinant adenoviruses: routes of immunization modulate virus-induced Ig subclass shifts.对重组腺病毒衣壳成分的体液免疫反应：免疫途径调节病毒诱导的Ig亚类转换。
Eur J Immunol. 1997 Mar;27(3):653-9. doi: 10.1002/eji.1830270312.
10
Immunogenicity of recombinant adenovirus-respiratory syncytial virus vaccines with adenovirus types 4, 5, and 7 vectors in dogs and a chimpanzee.用4型、5型和7型腺病毒载体构建的重组腺病毒-呼吸道合胞病毒疫苗在犬和黑猩猩中的免疫原性。
J Infect Dis. 1992 Oct;166(4):769-75. doi: 10.1093/infdis/166.4.769.
引用本文的文献
1
Vaccine development for human mastadenovirus.人类乳腺病毒的疫苗研发
J Thorac Dis. 2018 Jul;10(Suppl 19):S2280-S2294. doi: 10.21037/jtd.2018.03.168.
2
Suppression of nicotine-induced pathophysiology by an adenovirus hexon-based antinicotine vaccine.基于腺病毒六邻体的抗尼古丁疫苗抑制尼古丁引起的病理生理学变化。
Hum Gene Ther. 2013 Jun;24(6):595-603. doi: 10.1089/hum.2012.245.
3
Humoral and cellular immunity to hepatitis B virus-derived antigens: comparative activity of Freund complete adjuvant alum, and liposomes.针对乙肝病毒衍生抗原的体液免疫和细胞免疫：弗氏完全佐剂、明矾和脂质体的比较活性。
Infect Immun. 1980 Dec;30(3):728-33. doi: 10.1128/iai.30.3.728-733.1980.
4
In vivo induction of anti-herpes simplex virus immune response by type 1 antigens and lipid A incorporated into liposomes.通过掺入脂质体的1型抗原和脂多糖在体内诱导抗单纯疱疹病毒免疫反应。
Infect Immun. 1982 Jun;36(3):1209-16. doi: 10.1128/iai.36.3.1209-1216.1982.
5
6
Immunization against experimental murine salmonellosis with liposome-associated O-antigen.用脂质体相关 O 抗原对实验性小鼠沙门氏菌病进行免疫接种。
Infect Immun. 1985 Jun;48(3):658-63. doi: 10.1128/iai.48.3.658-663.1985.
本文引用的文献
1
IMMUNIZATION OF VOLUNTEERS WITH SOLUBLE ANTIGENS OF ADENOVIRUS TYPE 1.用1型腺病毒可溶性抗原对志愿者进行免疫接种。
Proc Soc Exp Biol Med. 1964 Oct;117:186-90. doi: 10.3181/00379727-117-29531.
2
PRODUCTION OF SPECIFIC NEUTRALIZING ANTIBODY WITH SOLUBLE ANTIGENS OF TYPE 5 ADENOVIRUS.用5型腺病毒可溶性抗原产生特异性中和抗体
Proc Soc Exp Biol Med. 1963 Oct;114:37-42. doi: 10.3181/00379727-114-28579.
3
Incorporation of lysozyme into liposomes. A model for structure-linked latency.溶菌酶掺入脂质体。结构关联潜伏的模型。
J Biol Chem. 1970 Jul 10;245(13):3295-301.
4
Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range.荧光胺：一种用于测定皮摩尔范围内氨基酸、肽、蛋白质和伯胺的试剂。
Science. 1972 Nov 24;178(4063):871-2. doi: 10.1126/science.178.4063.871.
5
Crystallization of a second adenovirus protein (the fibre).第二种腺病毒蛋白（纤维蛋白）的结晶。
Nature. 1971 Apr 16;230(5294):456-7. doi: 10.1038/230456a0.
6
Crystallization of an adenovirus protein (the hexon).一种腺病毒蛋白（六邻体）的结晶
Nature. 1968 Aug 31;219(5157):946-7. doi: 10.1038/219946a0.
7
Release of macromolecular markers (enzymes) from liposomes treated with antibody and complement. An attempt at correlation with electron microscopic observations.抗体和补体处理的脂质体中大分子标志物（酶）的释放。与电子显微镜观察结果的相关性研究。
Biochim Biophys Acta. 1973 Mar 16;298(2):158-79. doi: 10.1016/0005-2736(73)90347-7.
8
Preparation of liposomes and a spectrophotometric assay for release of trapped glucose marker.脂质体的制备及用于检测包封葡萄糖标记物释放的分光光度法测定
Methods Enzymol. 1974;32:501-13. doi: 10.1016/0076-6879(74)32050-2.
9
Liposomes as immunological adjuvants.脂质体作为免疫佐剂。
Nature. 1974 Nov 15;252(5480):252. doi: 10.1038/252252a0.
10
Induction of immunity in man by crystalline adenovirus type 5 capsid antigens.5型腺病毒结晶衣壳抗原在人体中诱导免疫反应。
Proc Soc Exp Biol Med. 1973 Sep;143(4):905-10. doi: 10.3181/00379727-143-37438.
Zotero 插件